Entering text into the input field will update the search result below

Interventional Cardiology Devices Market Development And Business Intelligence

Mar. 19, 2021 8:38 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Major factors influencing the growth of the market.
  • Leading players & Top Segments.
  • Geographic Overview.

Market growth influenced due to following factors-

  • Rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases.
  • Approval of new and advanced products.
  • Growing preference for minimally invasive surgeries.

Global market size-

According to the new market research report Interventional Cardiology Devices Market is projected to reach $21.2 billion by 2025, at a CAGR of 8.9%. 

Leading Players-

Some of the major players in the interventional cardiology devices market include Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Edward Lifescinces Corporation (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany). 

Top Market Segments-

Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.

Based on type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2019, the thrombectomy devices segment accounted for the largest share of the plaque modification devices market. Growth in this market segment can largely be attributed to the increasing incidence of blood clots and atrial embolisms across the globe. 

For Details, Download PDF Brochure

Geographic Overview -

North America accounted for the largest share of the interventional cardiology market in 2019. The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the growing geriatric population, and the strong presence of industry players in the region.


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.